We identified CHEK2-path variants in 2% (5/214) of MDS patients in this dataset, and did not observe CHEK2 p.I157T, consistent with the expected population distribution of this allele (Fig. 5D). Here, CHEK2 is linked to myelodysplastic syndrome.